Clinical Trials on Advanced Malignancy in Hong Kong
Total 184 results
-
Chinese University of Hong KongRecruiting
-
The University of Hong KongRecruitingAdvanced Care PlanningHong Kong
-
New Beta Innovation LimitedTerminated
-
The University of Hong KongQueen Mary Hospital, Hong KongCompletedAdvanced Cancer | AcupressureHong Kong
-
Chinese University of Hong KongRecruitingMalignant Biliary ObstructionHong Kong
-
Chinese University of Hong KongNot yet recruiting
-
The University of Hong KongRecruitingOlder Adults | Advance Care Planning | Family Members | Advance DirectivesHong Kong
-
The University of Hong KongNot yet recruitingPain Management | MalignancyHong Kong
-
The University of Hong KongCompletedMalignant Childhood NeoplasmChina
-
The University of Hong KongQueen Elizabeth Hospital, Hong Kong; Prince of Wales Hospital, Shatin, Hong... and other collaboratorsUnknownMalignant Pleural EffusionHong Kong
-
AstraZenecaCompletedAdvanced Solid MalignanciesChina
-
Chinese University of Hong KongTerminatedPancreatic Cancer | Hepatic Malignant TumorsHong Kong
-
Hong Kong Children's HospitalThe University of Hong KongRecruitingCarcinoma | Cancer | Solid Tumor | MalignancyHong Kong
-
The University of Hong KongRecruitingCancer | Graft Vs Host Disease | Haematological MalignancyHong Kong
-
New Epsilon Innovation LimitedActive, not recruitingAdvanced Solid Tumor | Relapsed AML | Refractory AMLHong Kong
-
Chinese University of Hong KongRecruitingPericardial Effusion MalignantHong Kong
-
Organisation for Oncology and Translational ResearchUnknownHormone Receptor Positive Malignant Neoplasm of BreastChina
-
The University of Hong KongResearch Grants Council, Hong KongRecruitingFear of Cancer Progression | Metacognition-based Intervention | Supportive-expressive Based Intervention | Psychooncology | Advanced or Metastatic CancerHong Kong
-
Aegera TherapeuticsChinese University of Hong KongCompletedAdvanced Hepatocellular CarcinomaChina
-
The University of Hong KongRecruitingPleural Effusion, Malignant | Lung Cancer Stage IV | Chest TubesHong Kong
-
The University of Hong KongQueen Mary Hospital, Hong KongRecruitingTai-Chi and Aerobic Exercise to Improve Emotional Symptom Cluster in Late-stage Lung Cancer PatientsAdvanced Lung Non-Small Cell CarcinomaHong Kong
-
Chinese University of Hong KongCompletedAdvanced Nasopharyngeal CarcinomaHong Kong
-
The University of Hong KongCompletedLung Cancer | Pleural Effusion, MalignantHong Kong
-
Lee's Pharmaceutical LimitedRecruitingAdvanced Hepatocellular CarcinomaChina
-
Chinese University of Hong KongTerminatedIntractable Abdominal Pain Secondary to Inoperable MalignancyChina
-
Chinese University of Hong KongNational University Hospital, Singapore; Singapore General Hospital; Changi General... and other collaboratorsCompletedUnresectable Malignant Gastric Outlet ObstructionChina
-
Zai Lab (Shanghai) Co., Ltd.TerminatedAdvanced Hepatocellular Carcinoma (HCC)China
-
The University of Hong KongUnknownAdvanced Hepatocellular Carcinoma | Metastatic Hepatocellular CarcinomaChina
-
Chinese University of Hong KongRecruitingColorectal Adenoma | Colorectal Polyp | Advanced AdenomaHong Kong
-
Abbott Medical DevicesTerminated
-
AmgenActive, not recruitingAdvanced/Metastatic Solid Tumors With KRAS p.G12C MutationTaiwan, Hong Kong
-
Chinese University of Hong KongRoche DiagnosticsRecruitingHeart Failure | Infections | Renal Failure | Cirrhosis | Fluid Overload | Pleural Effusion | Malignant Neoplasm | HypoalbuminemiaHong Kong
-
AstraZenecaCompletedCancer | Advanced Hepatocellular CarcinomaKorea, Republic of, Hong Kong
-
Chinese University of Hong KongTokyo Medical University; Kinki UniversityCompletedMalignant Biliary ObstructionAustralia, Denmark, China, Japan, Belgium
-
Novartis PharmaceuticalsCompletedMedulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor CancersTaiwan, Hong Kong, Japan
-
PfizerTerminatedAdvanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)United States, Spain, Hong Kong, Belgium, Australia, France
-
Novartis PharmaceuticalsTerminatedAdvanced Hepatocellular Carcinoma With c-MET DysregulationChina, Hong Kong, Thailand, Singapore
-
Harbour BioMed US, Inc.CompletedAdvanced Solid TumorAustralia, China, Hong Kong
-
AstraZenecaIonis Pharmaceuticals, Inc.CompletedAdvanced Adult Hepatocellular Carcinoma | Hepatocellular Carcinoma MetastaticKorea, Republic of, Taiwan, Hong Kong, Japan
-
Novartis PharmaceuticalsWithdrawnAdvanced Hepatocellular CarcinomaGermany, Australia, Hong Kong, Switzerland, Spain, France, United States
-
Puma Biotechnology, Inc.CompletedBreast Neoplasms | Advanced Breast Cancer | Advanced Malignant Solid TumorsUnited States, Belgium, China, Hong Kong, Canada, Korea, Republic of, India, Poland, Ukraine
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
Treadwell Therapeutics, IncTIO Discovery EngineRecruitingAdvanced Solid MalignanciesUnited States, Hong Kong, Canada
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Malignant Solid TumorsUnited States, Taiwan, United Kingdom, Hong Kong, Belgium, France, Spain, China, Netherlands, Poland, Sweden
-
Yiviva Inc.RecruitingAdvanced Hepatocellular CarcinomaUnited States, Taiwan, China, Hong Kong
-
Smith & Nephew, Inc.RecruitingAdvanced Degeneration of the Hip Joint | Revision of the Hip JointUnited States, Canada, Australia, Hong Kong, India
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited States, Korea, Republic of, Taiwan, France, Hong Kong, Belgium, Spain
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive, HER2-negative, Advanced Breast CancerJapan, Hong Kong, Singapore
-
Kyoto Breast Cancer Research NetworkPfizerCompletedHormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer FemaleTaiwan, Japan, Korea, Republic of, Australia, Hong Kong